The abstract is read at the publisher; the summary is JClub's.
KCTD1/KCTD15 pentameric complexes repress AP-2α and AP-2β in neural crest cells, and their loss in mice causes aplasia cutis congenita and multiple craniofacial defects.
- Why it matters: The in vivo downstream mechanism linking KCTD1/KCTD15 mutations to neural crest-dependent craniofacial and scalp skin phenotypes is unclear, limiting understanding of aplasia cutis congenita.
- What they did: Using conditional mouse models, cell lineage tracing, and genetic epistasis, the study tested whether KCTD1/KCTD15 control neural crest development by repressing AP-2α/AP-2β transcriptional activity.
- The result: Reducing AP-2α and AP-2β dosage in NCCs lacking KCTD1/KCTD15 markedly rescued defects, while NCC-specific AP-2α/AP-2β loss produced partially overlapping craniofacial abnormalities, supporting a KCTD1/KCTD15–AP-2 regulatory axis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.